In the early rule-out of myocardial infarction, outcomes may be improved by accounting for the patient’s out-of-hospital experience, improving reassurance communication, and discussing future goals for cardiovascular health.
The duration of carotid blood flow reversal during transcarotid artery revascularization for carotid bifurcation stenosis was not found to affect the rate of stroke, myocardial infarction, or death.
The use of a biodegradable polymer drug-eluting stent during percutaneous coronary intervention was associated with better long-term outcomes compared with a second-generation durable polymer drug-eluting stent in the treatment of patients with acute myocardial infarction.
The performance of a European Society of Cardiology algorithm in ruling out acute myocardial infarction without ST-elevation was comparable in patients with and without diabetes mellitus.
Abdominal obesity is associated with an increased risk for recurrent atherosclerotic cardiovascular disease after myocardial infarction.
Ethylene glycol toxicity was found to be associated with ST-elevation mimicking myocardial infarction and diffuse repolarization abnormalities.
Coronary microvascular dysfunction was found to be associated with an increased risk for cardiovascular events and cardiac dysfunction in patients with chronic kidney disease.
Routine oxygen therapy was not found to be associated with improved cardiovascular outcomes in normoxemic patients with confirmed myocardial infarction.
The presence of hyperlipidemia following hospitalization for acute myocardial infarction or acute decompensated heart failure may be associated with reduced mortality.
Non-vitamin K antagonist oral anticoagulants may be associated with lower risks for adverse events requiring hospitalization and reduced rates of major bleeding compared with vitamin K antagonists in patients receiving PCI for non-valvular atrial fibrillation who have an indication for anticoagulation.
